Penny Mohr, MA, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute, discusses comparative effectiveness research, healthcare disparities, and patient-centered care at the 20th annual international meeting of ISPOR.
Penny Mohr, MA, senior program officer for improving healthcare systems at the Patient-Centered Outcomes Research Institute (PCORI), discusses comparative effectiveness research, healthcare disparities, and patient-centered care at the 20th annual international meeting of ISPOR.
What is the importance of comparative effectiveness research on patient-centered care?
I think it’s very essential for patient-centered care because comparative effectiveness research by definition is really to look at choices that are appropriate to patients. And so when you’re looking at those choices and doing research on which item works better than the other, the patients are making those choices and the research really needs to inform those choices. So it should relate directly back to patient-centered care.
What work is PCORI currently doing to address healthcare disparities?
We have invested over $150 million in addressing disparities research and it is one of our 5 major priorities within PCORI when the initial plan of priorities was identified by the organization. Addressing disparities is built directly into the mission for the organization.
There are several population groups that we are focusing that are high-priority population groups for addressing disparities. And those include the low-income population, people who don’t speak English, the LGBT population, racial and ethnic minorities, and rural populations. Those are the major populations that we’re focusing on. We have also several major initiatives in this area looking at reducing obesity and also reducing hypertension.
What are some of the challenges of addressing and closing the healthcare disparities gap?
First of all, the research is very different than a lot of comparative effectiveness research. It involved multi-level, multi-component, complex interventions, and you have to think a lot of what are the barriers and facilitators, and it’s quite complex to think through that in order to get an intervention that works.
In addition you want to be looking at of different subpopulations as well within the groups. For instance, if you’re looking at the Hispanic population, there are a few levels of differences and how you will potentially approach the barriers that they face.
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen